9 April 2014 - Deborah Wilkes
Archived
Omega Pharma reported sales up by 16% to €1.21 billion (US$1.68 billion) in 2013, thanks to "good results" for its top 20 brands and a "full-year contribution" from the GlaxoSmithKline products acquired in 2012.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.